Old Mutual Limited (OMU) — Investment Research Note
Executive summary
Old Mutual is a 181-year-old pan-African financial services group (life insurance, asset management, P&C, and nascent retail bank) with primary operations in South Africa and 11 other African markets, dual-listed on JSE/LSE. Across the 2021–2026 period the group recovered from COVID-19 mortality shocks, unbundled Nedbank (R49.5bn returned), transitioned to IFRS 17, repurchased R4.5bn of shares, and set clearer strategic priorities around OM Bank, Life/Savings competitiveness and cost reduction; H1 2026 showed Life APE sales +21%, VNB +32%, RFO/share +11%, and RoGEV lifting to 12.7% 2026-09 interim. Headline point for valuation: the shares trade at ~0.70x group equity value per share (R20.66 at H1 2026) and ~8x normalised earnings in a listing where capital is being actively returned via progressive dividends and buybacks.
Fair value estimate
Methodology: triangulation of (i) discount to group equity value, (ii) forward P/E on adjusted headline earnings, (iii) dividend yield.
Using ZAR/GBP ~23.5 (R → p):
- Group Equity Value per share (H1 2026): R20.66 ≈ 88p. SA peer group typically trades at 0.75–0.90x GEV → 66–79p.
- Earnings: FY2025 AHEPS R1.898 ≈ 8.1p; applying 8–10x → 65–81p. Current P/E ~7.6x.
- Dividend: FY2025 DPS 93c (~4.0p), growing 6–8%. At 5.5–6.5% yield → 62–73p.
Fair value range: 65p – 80p per share (mid ≈ 72.5p). Implied market-cap range: £2,625m – £3,230m (mid ≈ £2,928m). Vs current £2,488.7m: mid-case upside ~18%.
Stock is modestly undervalued but no screaming bargain — a classic South-African-financials holding-company discount reflecting ZAR macro, Zimbabwe hyperinflation noise, and OM Bank losses funded during the ramp.
Sector context
Confirmed as Insurance (ICB Financials). OMU's quality/growth/leverage profile is broadly in line with SA peers: lower growth than African banking names, lower ROE than UK/EU life peers but comparable solvency. Natural listed comparables: Sanlam, Discovery, MMI/Momentum Metropolitan (South Africa); peripherally Prudential plc, Legal & General for life-insurance economics but very different geography.
Investment thesis (3 bullets)
- Deep valuation discount with active capital return: Shares at ~0.70x group equity value and <8x earnings while management delivered R3bn buyback (completed H1 2026) + a further R1bn authorised, plus 8% interim DPS growth. Discretionary capital R3.1bn post-buyback with another R2bn+ from OMLACSA dividend expected H2 2026 2026-09 interim.
- Operational momentum re-established: Life APE sales +21% and VNB +32% in H1 2026, cumulative cost savings R936m against R2.5bn target by 2027, RoGEV lifting to 12.7% from 4.1% in FY2025 2026-09 interim; 2025-10 CMD. Underwriting margin in OM Insure at upper end of 5–8% range despite catastrophes 2026-09 interim.
- OM Bank optionality now de-risked: Banking licence granted March 2025, 742k customers and R1.4bn deposits by H1 2026, pathway to break-even FY2028 clarified with run-rate loss of R1.1–1.3bn 2025-03 final; 2026-09 interim. If execution continues, bank losses roll off while deposit funding compounds.
Key risks (3 bullets)
- South African macro and currency: Earnings are ZAR-denominated and shareholder investment returns swung AHE from +29% H1 2025 to –30% H1 2026 purely on market direction 2025-09, 2026-09 interims. GBP-shareholder returns are hostage to the rand.
- Persistency and basis changes: FY2025 required strengthening of persistency assumptions in Mass & Foundation and raising the non-hedgeable risk capital charge from 2% to 3.5%, cutting VNB 50% in H1 2025 2025-09 interim. Methodology changes have made group equity value a moving target.
- Zimbabwe/Malawi hyperinflation and emerging-market tail risks: Malawi still accounted for as hyperinflationary, Zimbabwe excluded from AHE, functional-currency changes created R2.2bn IFRS swings in 2024 2025-03 final. Opaque, hard-to-value.
Operating leverage
Operating leverage is modest. Old Mutual's cost base is predominantly variable (commissions, claims, distribution incentives scale with premium), with fixed overheads being the central corporate functions and IT estate. The cost-savings programme targets R2.5bn by FY2027 off a 2024 base — material but not transformational given group RFO of ~R10bn. Insurance underwriting is partially capacity-constrained (OM Insure delivered 420-bps net underwriting-margin expansion H1 2024 vs H1 2023 on only 9% top-line growth 2024-09 interim — a genuine display of fixed-cost leverage), and the asset-management business carries meaningful operating leverage on AUM (R1,731bn at H1 2026, +6% YTD). But life sales growth drops to profit at ~1.3–1.5% VNB margin, so a 10–20% life revenue surprise would add only R100–150m to VNB — a few percent of adjusted HE, not multiples. Score: around 35.
Value-trap signals
- Persistent discount to group equity value for the whole LSE listing history (>5 years), suggesting a structural holding-company / rand discount rather than temporary mispricing.
- Multiple methodology and basis changes (persistency 2025, hedging 2022, cost allocation 2024) that reset reported value lower.
- Zimbabwe accounting complications (functional-currency switches, hyperinflation) permanently depress IFRS-profit visibility.
- Repeated exits from Africa Regions markets (Nigeria life/P&C, Tanzania P&C, South Sudan run-off) — reasonable triage but signals of past capital mis-allocation. These are not terminal — the business is cash-generative and solvent — but they explain why the discount persists.
Earnings vs. expectations
Pre-results trading statements consistently frame outcomes in wide ranges (±20%+) and the actuals have broadly landed in-range: H1 2025 AHE +29% within the +19–39% guided; FY2024 AHE +14% within the +4–24% range; H1 2024 AHE +3% within the –2 to +8% range trading statements 2024-09, 2025-03, 2025-08. Pattern: RFO tends to come in near the midpoint; AHE varies with shareholder investment returns which management does not predict. More "meet" than "beat" or "miss" — but reliability is average because the ranges themselves are wide.
Conviction
3 — moderate. Anchors: comprehensive IFRS 17 disclosure, group equity value is a well-established valuation anchor, multiple methodologies triangulate to a similar discount. Caveats: ZAR earnings translated to GBP introduce FX volatility outside any thesis; repeated methodology/basis changes have moved group equity value; Zimbabwe and OM Bank break-even are judgement calls, not evidence-based forecasts.